Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro

Bone

Volumn 24, Issue 4, 1999, Pages 337-347

  Molteni A ^a   Modrowski, D ^a   Hott, M ^a   Marie, P J ^a  

^a INSERM   (France)

Author keywords

Calvaria; Condyle; Fibroblast growth factor receptor (FGFR); Osteoblasts; Osteogenesis; Syndecans

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; SYNDECAN;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BONE DEVELOPMENT; CALVARIA; CELL DIFFERENTIATION; CHONDROGENESIS; GENE EXPRESSION; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MANDIBLE CONDYLE; NEWBORN; NONHUMAN; OSTEOBLAST; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; IMMUNOHISTOCHEMISTRY; MANDIBULAR CONDYLE; MEMBRANE GLYCOPROTEINS; ORGAN CULTURE TECHNIQUES; OSTEOGENESIS; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FIBROBLAST GROWTH FACTOR; SKULL; SYNDECAN-1; SYNDECAN-2; SYNDECAN-4; SYNDECANS; TUMOR CELLS, CULTURED;

EID: 0033120972     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00191-4     Document Type: Article

References (64)

1. Baciu P.C., Goetinch P.F. Protein kinase C regulates the recruitment of syndecan-4 into focal contacts. Mol Biol Cell. 6:1995;1503-1513.
2. Baron R., Vignery A., Neff L., Silverglate A., Maria A.S. Processings of undecalcified bone specimens for bone histomorphometry. Recker R.R., Bone Histomorphometry. 1983;13-36 CRC, Boca Raton, FL.
3. Ben-Ami Y., von der Mark K., Franzen A., de Bernard B., Lunazzi G.C., Silbermann M. Immunohistochemical studies of the extracellular matrix in the condylar cartilage of the human fetal mandible collagens and noncollagenous proteins . Am J Anat. 190:1991;157-166.
4. Bernfield M., Hinkes M.T., Gallo R.L. Developmental expression of the syndecans Possible function and regulation . Development. 119:(Suppl.):1993;205-212.
5. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., Lose E.J. Biology of the syndecans A family of transmembrane heparan sulfate proteoglycans . Annu Rev Cell Biol. 8:1992;365-393.
6. Bohme K., Winterhalter K.H., Bruckner P. Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by TGF-β2 and basic growth factor in synergy. Exp Cell Res. 216:1995;191-198.
7. Canalis E., Centrella M., McCarthy T. Effects of fibroblast growth factor on bone formation in vitro. J Clin Invest. 81:1988;1572-1577.
8. Canalis E., Raisz L.G. Effect of fibroblast growth factor on cultured fetal rat calvaria. Metabolism. 29:1980;108-112.
9. Carey D. Syndecans Multifunctional cell-surface co-receptors . Biochem J. 327:1997;1-16.
10. Chernousov M.A., Carey D.J. N-syndecan (syndecan-3) from neonatal rat brain binds fibroblast growth factor. J Biol Chem. 268:1993;16810-16814.
11. Cizmeci-Smith G., Langan E., Youkey J., Showalter L.J., Carey D.J. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial infury in vascular smooth muscle cells. Artherioscler Thromb Vasc Biol. 17:1997;172-180.
12. Couchman J.R., Woods A. Syndecans, signaling and cell adhesion. J Cell Biochem. 61:1996;578-584.
13. David G. Integral membranes heparan sulfate proteoglycans. FASEB J. 7:1993;1023-1030.
14. David G., Bai X.M., Van der Schueren B., Marynen P., Cassiman J.J., Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development. 119:1993;841-854.
15. Debiais F., Graulet A.M., Marie P.J. Fibroblast growth factor-2 differently affects human neonatal calvaria osteoblastic cells depending on the stage of cell differentiation. J Bone Miner Res. 13:1998;645-654.
16. Delezoide A.L., Benoist-Lasselin C., Legeai-Mallet L., Le Merrer M., Munnich A., Vekemans M., Bonaventure J. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Devel. 77:1998;19-30.
17. Deng C.X., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
18. Elenius K., Jalkanen M. Function of the syndecans - a family of cell surface proteoglycans. J Cell Sci. 107:1994;2975-2982.
19. Filla M.S., Dam P., Rapraeger A.C. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J Cell Physiol. 174:1998;310-321.
20. Frenz D.A., Liu W., Williams J.D., Hatcher V., Galinovic-Schwartz P., Flanders K.C., Van De Water T.R. Induction of chondrogenesis Requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta . Development. 120:1994;415-424.
21. Givol D., Yayon A. Complexity of FGF receptors Genetic basis for structural diversity and functional specificity . FASEB J. 6:1992;3362-3369.
22. Globus R.K., Patterson-Buckendahl P., Gospodarowicz D. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor β Endocrinology. 123:1988;98-105.
23. Gonzalez A.M., Hill D.J., Logan A., Maher P.A., Baird A. Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res. 39:1996;375-385.
24. Gospodarowicz D. Fibroblast growth factor. Crit Rev Oncogen. 1:1989;1-26.
25. Gould S.E., Upholt W.B., Kosher R.A. Syndecan-3 A member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation . Proc Natl Acad Sci USA. 89:1992;3271-3275.
26. Hurley M.M. Fibroblast growth factor and vascular endothelial cell growth factor families. Bilezikian J.P., Raisz L.G., Rodan G., Principles of Bone Biology. 1996;630-645 Academic, New York.
27. Iseki S., Wilkie A.O., Heath J.K., Ishimura T., Eto K., Morriss-Kay G.M. FGFR2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development. 124:1997;3375-3384.
28. Kato Y., Iwamoto M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem. 265:1990;5903-5909.
29. Kim C.W., Goldberger O.A., Gallo R.L., Bernfield M. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and developing-specific patterns. Mol Biol Cell. 7:1994;797-805.
30. Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 67:1991;229-231.
31. Larrain J., Alvarez J., Hassell J.R., Brandan E. Expression of perlecan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation. Exp Cell Res. 234:1997;405-412.
32. Legeai-Mallet L., Benoist-Lasselin C., Delezoide A.L., Munnich A., Bonaventure J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem. 273:1998;13007-13014.
33. Lomri A., Lemonnier J., Hott M., de Perseval N., Lajeunie E., Munnich A., Renier D., Marie P.J. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor-2 mutations in Apert syndrome. J Clin Invest. 101:1998;1310-1317.
34. Lowry O.H., Reosebrough N.J., Farr A.L., Randall R. J Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
35. Luan Y., Praul C.A., Gay C.V., Leach R.M. Jr. Basic fibroblast growth factor An autocrine growth factor for epiphyseal growth plate chondrocytes . J Cell Biochem. 62:1996;372-382.
36. Machwate M., Jullienne A., Moukhtar M., Marie P.J. Temporal variation of c-fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J Cell Biochem. 57:1995;62-70.
37. Modrowski, D., Lomri, A., Baslé, M. F., and Marie, P. J. Syndecan-2 binds GM-CSF and controls its mitogenic activity in human osteoblastic cells. J Bone Miner Res 12(Suppl. 1):230; 1997 (abstract).
38. Modrowski D., Lomri A., Marie P.J. Glycosaminoglycans bind granulocyte macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells. J Cell Physiol. 177:1998;187-195.
39. Molténi, A., Modrowski, D., Hott, M., and Marie, P. J. Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to FGF-2 in cultured rat mandibular condyle and calvaria. Cell Tissue Res. In press.
40. Muenke M., Schelle U. Fibroblast growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11:1995;308-313.
41. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F., Gao G., Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 271:1996;15292-15297.
42. Orr-Urtreger A., Givol D., Yayon A., Yarden Y., Lonai P. Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development. 113:1991;1419-1434.
43. Park W.J., Bellus G.A., Jabs E.W. Mutations in fibroblast growth factor receptors Phenotypic consequences during eukaryotic development . Am J Human Genet. 57:1995;748-754.
44. Partanen J., Vainikka S., Korhonen J., Armstrong E., Alitalo K. Diverse receptors for fibroblast growth factors. Progr Growth Factor Res. 4:1992;69-83.
45. Peters K., Ornitz D., Werner S., William L. Unique expression pattern of FGF receptor 3 gene during mouse organogenesis. Devel Biol. 155:1993;423-430.
46. Peters K.G., Werner S., Chen G., William L.T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development. 114:1992;233-243.
47. Rapraeger A.C. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr Opin Cell Biol. 5:1993;844-853.
48. Rousseau F., Bonaventure J., Legai-Mallet L., Pelet A., Rozet J.M., Maroteaux P., Le Merrer M., Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371:1994;252-254.
49. Seghatoleslami M.R., Kosher R.A. Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Devel Dynam. 207:1996;114-119.
50. Shimazu A., Nah H.D., Kirsch T., Koyama E., Leatherman J.L., Golden E.B., Kosher R.A., Pacifici M. Syndecan-3 and the control of chondrocyte proliferation during endochondral ossification. Exp Cell Res. 229:1996;126-136.
51. Silberman M., Lewinson D., Gonen H., Lizarbe M.A., von der Mark K. In vitro transformation of chondroprogenitor cells into osteoblasts and the formation of new membrane bone. Anat Rec. 206:1983;373-383.
52. Solursh M., Reiter R.S., Jensen K.L., Kato M., Bernfield M. Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development. Devel Biol. 140:1990;83-92.
53. Steinfeld R., Van Den Berghe H., David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol. 133:1996;405-416.
54. Strauss P.G., Closs E.I., Schmidt J., Erfle V. Gene expression during osteogenic differentiation in mandibular condyles in vitro. J Cell Biol. 110:1990;1369-1378.
55. Tang K.T., Capparelli C., Stein J.L., Stein G.S., Lian J.B., Huber A.C., Braverman L.E., DeVito W.J. Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro Altered expression of collagenase, cell growth-related, and mineralization-associated genes . J Cell Biochem. 61:1996;152-166.
56. Trautman M.S., Kimelman J., Bernfield M. Developmental expression of syndecan, an integral membrane proteoglycan, correlates with cell differentiation. Development. 111:1991;213-220.
57. Twal W.O., Vasilatos-Younken R., Gay C.V., Leach R.M. Isolation and localization of basic fibroblast growth factor-immunoreactive substance in the epiphyseal growth plate. J Bone Miner Res. 9:1994;1737-1744.
58. Vainio S., Jalkanen M., Vaahtokari A., Sahlberg C., Mali M., Bernfield M., Thesleff I. Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth organogenesis. Devel Biol. 147:1991;322-333.
59. Wanaka A., Milbrandt E.M., Johnson M. Expression of FGF receptor gene in rat development. Development. 111:1991;455-468.
60. Weinreb M., Shinar D., Rodan G. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res. 8:1990;831-842.
61. Weiss A., von der Mark K., Silbermann M. A tissue culture system supporting cartilage cell differentiation, extracellular mineralization, and subsequent bone formation, using mouse condylar progenitor cells. Cell Differ. 19:1986;103-113.
62. Wilke T.A., Gubbels S., Schwartz J., Richman J.M. Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Devel Dynam. 210:1997;41-52.
63. Wilkie A.O.M., Morriss-Kay G.M., Jones E.Y., Heath J.K. Functions of fibroblast growth factors and their receptors. Curr Biol. 5:1995;500-507.
64. Yayon A.M., Klagsbrun M., Asko J.D., Leder P., Ornitz D.M. Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor. Cell. 64:1991;841-848.